Active, not recruitingPHASE1, PHASE2NCT06471543
Study of RN0361in Adult Healthy Subjects and Adult Hypertriglyceridemic Subjects
Studying Familial chylomicronemia syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Ikaria Bioscience Pty Ltd
- Intervention
- RN0361(drug)
- Enrollment
- 108 enrolled
- Eligibility
- 18-70 years · All sexes
- Timeline
- 2024 – 2026
Study locations (10)
- TBC Research LLC,, Tamarac, Florida, United States
- Versailles Family Medicine / Avacare, Versailles, Kentucky, United States
- Axis Clinicals USA, Dilworth, Minnesota, United States
- Synergy Groups Medical, Houston, Texas, United States
- Tranquil, Webster, Texas, United States
- Ogden Clinic, Mountain View / Avacare, Pleasant View, Utah, United States
- University of the Sunshine Coast Clinical Trials, Morayfield, Queensland, Australia
- University of the Sunshine Coast Clinical Trials, Sippy Downs, Sippy Downs, Queensland, Australia
- Altona Clinical Research, Altona N., Victoria, Australia
- Nucleus Network Melbourne, Melbourne, Victoria, Australia
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06471543 on ClinicalTrials.gov